Business

Moderna, Inc. (MRNA) Q1 2026 Earnings Call Transcript

Published

on

Moderna, Inc. (MRNA) Q1 2026 Earnings Call May 1, 2026 8:00 AM EDT

Company Participants

Lavina Talukdar – Senior VP & Head of Investor Relations
Stéphane Bancel – CEO & Director
James Mock – Chief Financial Officer
Stephen Hoge – President

Advertisement

Conference Call Participants

Salveen Richter – Goldman Sachs Group, Inc., Research Division
Jessica Fye – JPMorgan Chase & Co, Research Division
Terence Flynn – Morgan Stanley, Research Division
Luca Issi – RBC Capital Markets, Research Division
Tyler Van Buren – TD Cowen, Research Division
Eliana Merle – Barclays Bank PLC, Research Division
Michael Yee – UBS Investment Bank, Research Division
Courtney Breen – Bernstein Institutional Services LLC, Research Division
Geoffrey Meacham – Citigroup Inc., Research Division
Cory Kasimov – Evercore ISI Institutional Equities, Research Division
Simon Baker – Rothschild & Co Redburn, Research Division
Lin Tsai – Jefferies LLC, Research Division
Alexandria Hammond – Wolfe Research, LLC

Presentation

Advertisement

Operator

Good day, and thank you for standing by. Welcome to Moderna’s First Quarter 2026 Conference Call. [Operator Instructions] Please be advised, today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Lavina Talukdar, Head of IR. Please go ahead.

Lavina Talukdar
Senior VP & Head of Investor Relations

Advertisement

Thank you, Kevin. Good morning, everyone, and thank you for joining us today to discuss Moderna’s First Quarter 2026 Financial Results and Business Update. You can access the press release issued this morning as well as the slides that we’ll be reviewing by going to the Investors section of our website.

On today’s call are Stéphane Bancel, our Chief Executive Officer; Stephen Hoge, our President; and Jamey Mock, our Chief Financial Officer.

Please note that this conference call will include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see Slide 2 of the accompanying presentation and our

Advertisement

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Trending

Exit mobile version